These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9669793)

  • 1. Pharmacogenetics and ethnoracial differences in smoking.
    Sellers EM
    JAMA; 1998 Jul; 280(2):179-80. PubMed ID: 9669793
    [No Abstract]   [Full Text] [Related]  

  • 2. CYP2A6 genetic polymorphisms and correlation with smoking status in Brazilians.
    Vasconcelos GM; Struchiner CJ; Suarez-Kurtz G
    Pharmacogenomics J; 2005; 5(1):42-8. PubMed ID: 15534625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation of CYP2A6, smoking, and risk of cancer.
    London SJ; Idle JR; Daly AK; Coetzee GA
    Lancet; 1999 Mar; 353(9156):898-9. PubMed ID: 10093988
    [No Abstract]   [Full Text] [Related]  

  • 4. CYP2A6 polymorphism, nicotine, and environmental nitrosamines.
    Idle JR
    Lancet; 1999 Jun; 353(9169):2073. PubMed ID: 10376647
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic polymorphism of S-mephenytoin 4'-hydroxylation in African-Americans.
    Edeki TI; Goldstein JA; de Morais SM; Hajiloo L; Butler M; Chapdelaine P; Wilkinson GR
    Pharmacogenetics; 1996 Aug; 6(4):357-60. PubMed ID: 8873222
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytochrome P450 2C19 gene polymorphism in four Chinese nationality populations].
    Zhang S; Dong Z; Tang L; Zhou Q; Wu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):52-4. PubMed ID: 11836688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2A6 genotype and smoking.
    Tiihonen J; Pesonen U; Kauhanen J; Koulu M; Hallikainen T; Leskinen L; Salonen JT
    Mol Psychiatry; 2000 Jul; 5(4):347-8. PubMed ID: 10889542
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of correlation between CYP2A6 genotype and smoking habits.
    Schulz TG; Ruhnau P; Hallier E
    Adv Exp Med Biol; 2001; 500():213-5. PubMed ID: 11764938
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of association between smoking and CYP2A6 gene polymorphisms in A Japanese population.
    Zhang X; Amemo K; Ameno S; Iwahashi K; Kinoshita H; Kubota T; Mostofa J; Ijiri I
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2001 Oct; 36(5):486-90. PubMed ID: 11725533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
    Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase.
    Oscarson M; Gullstén H; Rautio A; Bernal ML; Sinues B; Dahl ML; Stengård JH; Pelkonen O; Raunio H; Ingelman-Sundberg M
    FEBS Lett; 1998 Nov; 438(3):201-5. PubMed ID: 9827545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic CYP2A6 and its clinical and toxicological significance.
    Rautio A
    Pharmacogenomics J; 2003; 3(1):5-7. PubMed ID: 12629576
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics of cytochromes P450.
    Hasler JA
    Mol Aspects Med; 1999; 20(1-2):12-24, 25-137. PubMed ID: 10575648
    [No Abstract]   [Full Text] [Related]  

  • 14. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
    Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic differences in nicotine metabolic rate among New Zealanders.
    Lea R; Benowitz N; Green M; Fowles J; Vishvanath A; Dickson S; Lea M; Woodward A; Chambers G; Phillips D
    N Z Med J; 2005 Dec; 118(1227):U1773. PubMed ID: 16372023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two single-tube tetra-primer assays to detect the CYP2C19*2 and *3 alleles of S-mephenytoin hydroxylase.
    Hersberger M; Marti-Jaun J; Rentsch K; Hänseler E
    Clin Chem; 2001 Apr; 47(4):772-4. PubMed ID: 11274039
    [No Abstract]   [Full Text] [Related]  

  • 17. Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies.
    Nowak MP; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 1998 Oct; 64(4):378-83. PubMed ID: 9797794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotyping human CYP2A6 variants.
    Goodz SD; Tyndale RF
    Methods Enzymol; 2002; 357():59-69. PubMed ID: 12424898
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotine metabolism varies between different ethnic groups.
    Pirisi A
    Lancet; 2002 Jan; 359(9302):234. PubMed ID: 11812565
    [No Abstract]   [Full Text] [Related]  

  • 20. CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis.
    Gullstén H; Agúndez JA; Benítez J; Läärä E; Ladero JM; Díaz-Rubio M; Fernandez-Salguero P; Gonzalez F; Rautio A; Pelkonen O; Raunio H
    Pharmacogenetics; 1997 Jun; 7(3):247-50. PubMed ID: 9241665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.